Viktor Berge, Rolf Eigil Berg, Jon Roar Hoff, Nicolai Wessel, Aud Svindland, Steinar Johan Karlsen, Lars Magne Eri
{"title":"577例腹腔镜根治性前列腺切除术治疗局限性前列腺癌患者的5年无进展生存率","authors":"Viktor Berge, Rolf Eigil Berg, Jon Roar Hoff, Nicolai Wessel, Aud Svindland, Steinar Johan Karlsen, Lars Magne Eri","doi":"10.3109/00365599.2011.604790","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Laparoscopic radical prostatectomy (LRP) was introduced in the Department of Urology, Oslo University Hospital, in 2002. The aim of this study was to report mid-term oncology results and survival data.</p><p><strong>Material and methods: </strong>From February 2002 to November 2007, 582 consecutive patients with localized prostate cancer underwent LRP. Data were collected prospectively into a database.</p><p><strong>Results: </strong>Mean and median follow-up after LRP was 30.3 months (± 15.5) and 36.0 months (range 3-72). Five patients (1%) were lost during follow-up. Two patients died of prostate cancer during the study period and 10 patients died of other causes. The overall positive surgical margin (PSM) rate was 29% and decreased to 13% for the last 100 patients. The overall PSA progression-free survival (PFS) was 85% at 3 years and 73% at 5 years. Gleason score in the tumour specimen, pT stage and surgical margins were statistical significant independent predictors of biochemical PFS.</p><p><strong>Conclusion: </strong>These oncology results and 5-year PFS data after LRP are in line with other reports.</p>","PeriodicalId":21543,"journal":{"name":"Scandinavian Journal of Urology and Nephrology","volume":"46 1","pages":"8-13"},"PeriodicalIF":0.0000,"publicationDate":"2012-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365599.2011.604790","citationCount":"8","resultStr":"{\"title\":\"Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer.\",\"authors\":\"Viktor Berge, Rolf Eigil Berg, Jon Roar Hoff, Nicolai Wessel, Aud Svindland, Steinar Johan Karlsen, Lars Magne Eri\",\"doi\":\"10.3109/00365599.2011.604790\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Laparoscopic radical prostatectomy (LRP) was introduced in the Department of Urology, Oslo University Hospital, in 2002. The aim of this study was to report mid-term oncology results and survival data.</p><p><strong>Material and methods: </strong>From February 2002 to November 2007, 582 consecutive patients with localized prostate cancer underwent LRP. Data were collected prospectively into a database.</p><p><strong>Results: </strong>Mean and median follow-up after LRP was 30.3 months (± 15.5) and 36.0 months (range 3-72). Five patients (1%) were lost during follow-up. Two patients died of prostate cancer during the study period and 10 patients died of other causes. The overall positive surgical margin (PSM) rate was 29% and decreased to 13% for the last 100 patients. The overall PSA progression-free survival (PFS) was 85% at 3 years and 73% at 5 years. Gleason score in the tumour specimen, pT stage and surgical margins were statistical significant independent predictors of biochemical PFS.</p><p><strong>Conclusion: </strong>These oncology results and 5-year PFS data after LRP are in line with other reports.</p>\",\"PeriodicalId\":21543,\"journal\":{\"name\":\"Scandinavian Journal of Urology and Nephrology\",\"volume\":\"46 1\",\"pages\":\"8-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3109/00365599.2011.604790\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Urology and Nephrology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/00365599.2011.604790\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2011/8/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Urology and Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/00365599.2011.604790","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/8/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer.
Objective: Laparoscopic radical prostatectomy (LRP) was introduced in the Department of Urology, Oslo University Hospital, in 2002. The aim of this study was to report mid-term oncology results and survival data.
Material and methods: From February 2002 to November 2007, 582 consecutive patients with localized prostate cancer underwent LRP. Data were collected prospectively into a database.
Results: Mean and median follow-up after LRP was 30.3 months (± 15.5) and 36.0 months (range 3-72). Five patients (1%) were lost during follow-up. Two patients died of prostate cancer during the study period and 10 patients died of other causes. The overall positive surgical margin (PSM) rate was 29% and decreased to 13% for the last 100 patients. The overall PSA progression-free survival (PFS) was 85% at 3 years and 73% at 5 years. Gleason score in the tumour specimen, pT stage and surgical margins were statistical significant independent predictors of biochemical PFS.
Conclusion: These oncology results and 5-year PFS data after LRP are in line with other reports.